Option Care Health, Inc Credit Rating

Results 1 - 50 Of 61

Page Of 2 Next

Filter By:

Date	Document Type	Title	Source
20 Dec 2023	Rating Action	Moody's assigns Ba2 to Option Care's new revolver	Moody's Investors Service
17 Aug 2023	LGD Assessment	Option Care Health, Inc: Loss Given Default (LGD) Assessment	Moody's Investors Service
20 Jul 2023	Credit Opinion	Option Care Health, Inc: Update to credit analysis following upgrade to Ba3	Moody's Investors Service
19 Jul 2023	Rating Action	Moody's upgrades Option Care's CFR to Ba3; outlook stable	Moody's Investors Service
28 Jun 2023	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Business and Consumer Service issuers	Moody's Investors Service
09 May 2023	Credit Opinion	Option Care Health, Inc: Update to credit analysis following review for upgrade	Moody's Investors Service
05 May 2023	Rating Action	Moody's places Option Care's ratings on review for upgrade on proposed merger with Amedisys	Moody's Investors Service
28 Oct 2022	Credit Opinion	Option Care Health, Inc: Update to credit analysis	Moody's Investors Service
01 Aug 2022	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Healthcare Service issuers	Moody's Investors Service
07 Dec 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Option Care Health, Inc	Moody's Investors Service
15 Nov 2021	Covenant Quality Assessment	Option Care Health, Inc: Covenant Quality Post-Sale Snapshot: $500m 4.375% Senior Notes due 2029	Moody's Investors Service
25 Oct 2021	LGD Assessment	Option Care Health, Inc	Moody's Investors Service
22 Oct 2021	Credit Opinion	Option Care Health, Inc: Discussion of key credit factors following the upgrade to B1	Moody's Investors Service
20 Oct 2021	Rating Action	Moody's assigns a B3 to Option Care's senior unsecured notes	Moody's Investors Service
19 Oct 2021	Rating Action	Moody's upgrades Option Care Health, Inc's Corporate Family Rating to B1; outlook stable	Moody's Investors Service
03 Feb 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Option Care Health, Inc	Moody's Investors Service
25 Jan 2021	LGD Assessment	OPCH LGD Assessment	Moody's Investors Service
21 Jan 2021	Credit Opinion	Option Care Health, Inc: Discussion of Key Credit Factors Following the Upgrade to B2	Moody's Investors Service
15 Jan 2021	Rating Action	Moody's upgrades Option Care Health, Inc.'s Corporate Family Rating to B2; outlook stable	Moody's Investors Service
08 Oct 2020	LGD Assessment	Option Care Health, Inc	Moody's Investors Service
25 Aug 2020	Credit Opinion	Option Care Health, Inc: Discussion of Key Credit Factors Following the Positive Outlook	Moody's Investors Service
21 Aug 2020	Rating Action	Moody's affirms Option Care Health, Inc.'s B3 CFR; outlook positive	Moody's Investors Service
05 May 2020	Credit Opinion	Option Care Health, Inc.: Discussion of Key Credit Factors	Moody's Investors Service
05 Mar 2020	Covenant Quality Assessment	BioScrip, Inc. (Option Care Health, Inc.): Loan Covenant Quality Snapshot	Moody's Investors Service
05 Mar 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Option Care Health, Inc.	Moody's Investors Service
14 Jun 2019	LGD Assessment	Bioscrip, Inc.	Moody's Investors Service
17 May 2019	Credit Opinion	BioScrip, Inc.: Discussion of Key Credit Factors following upgrade	Moody's Investors Service
14 May 2019	Rating Action	Moody's upgrades BioScrip, Inc.'s Corporate Family Rating to B3, outlook stable	Moody's Investors Service
18 Apr 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Bioscrip, Inc.	Moody's Investors Service
18 Mar 2019	Rating Action	Moody's places BioScrip's ratings under review for upgrade following the announced merger with HC Group Holdings	Moody's Investors Service
19 Sep 2018	LGD Assessment	BioScrip, Inc.	Moody's Investors Service
01 Aug 2018	Credit Opinion	BioScrip, Inc.: Update following upgrade to Caa1	Moody's Investors Service
30 Jul 2018	Rating Action	Moody's upgrades BioScrip's CFR to Caa1; outlook stable	Moody's Investors Service
13 Jul 2018	LGD Assessment	BioScrip, Inc.	Moody's Investors Service
02 Aug 2017	Credit Opinion	BioScrip, Inc.: Discussion Following the Refinancing	Moody's Investors Service
01 Aug 2017	Rating Action	Moody's rates BioScrip's new debt; Caa2 CFR affirmed	Moody's Investors Service
01 Mar 2017	Credit Opinion	BioScrip, Inc.: Discussion of Key Credit Factors	Moody's Investors Service
21 Apr 2016	Issuer In-Depth	BioScrip, Inc.: Unlikely to Hit Cost-Cutting Targets as Liquidity and Other Credit Risks Mount	Moody's Investors Service
03 Mar 2016	Credit Opinion	BioScrip, Inc.: Discussion of Key Credit Factors	Moody's Investors Service
03 Mar 2016	Rating Action	Moody's downgrades BioScrip's CFR to Caa2; outlook stable	Moody's Investors Service
14 Dec 2015	Announcement	Moody's retires Healthcare Service Providers Industry Rating Methodology	Moody's Investors Service
13 May 2015	Credit Focus	U.S. Home Infusion Service Providers: BioScrip and Walgreens Infusion Services: Peer Comparison	Moody's Investors Service
13 Mar 2015	Announcement	Moody's: BioScrip's convertible preferred stock issuance is credit positive; ratings unaffected	Moody's Investors Service
12 Mar 2015	Issuer Comment	BioScrip, Inc.: Moody’s: BioScrip’s convertible preferred stock issuance is credit positive; ratings unaffected	Moody's Investors Service
05 Mar 2015	Rating Action	Moody's downgrades BioScrip's CFR to Caa1; outlook stable	Moody's Investors Service
05 Mar 2015	Credit Opinion	BioScrip, Inc.	Moody's Investors Service
24 Mar 2014	LGD Assessment	BioScrip, Inc.	Moody's Investors Service
05 Feb 2014	Rating Action	Moody's rates BioScrip's proposed senior unsecured notes Caa2; B3 CFR affirmed; stable outlook	Moody's Investors Service
03 Feb 2014	Issuer Comment	Moody's: BioScrip's term loan amendment and pending sale of Home Health is credit positive; B3 CFR and stable outlook unaffected	Moody's Investors Service
03 Feb 2014	Announcement	Moody's: BioScrip's term loan amendment and pending sale of Home Health is credit positive; B3 CFR and stable outlook unaffected	Moody's Investors Service

Results 1 - 50 Of 61

Page Of 2 Next

Research & Ratings

Products & Solutions

News & Events

Registered User

Not Registered Yet?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: